citalopram has been researched along with Tremor in 9 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We performed the first trial to investigate whether dystonic jerks/tremor in patients with CD respond to the selective serotonin reuptake inhibitor (SSRI) escitalopram." | 9.27 | Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor. ( Aramideh, M; Bienfait, H; Booij, J; Boon, AJW; Brans, JWM; Delnooz, CCS; Dijk, JM; Dreissen, YEM; Hoogerwaard, E; Hovestadt, A; Kamphuis, DJ; Koelman, JHTM; Munts, AG; Skorvanek, M; Smit, M; Speelman, JD; Tijssen, MAJ; van der Salm, SMA; Zoons, E, 2018) |
| "Side effects such as myoclonus and tremor are rare when treating with selective serotonin reuptake inhibitors (SSRIs)." | 5.42 | [Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis]. ( Bode, M; Forsberg-Gillving, M; Sindrup, SH, 2015) |
| "Tremor is the second most common neurological adverse effect in patients receiving treatment with SSRIs." | 5.32 | Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats. ( Al Deeb, S; Al Kadasah, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2004) |
| " We performed the first trial to investigate whether dystonic jerks/tremor in patients with CD respond to the selective serotonin reuptake inhibitor (SSRI) escitalopram." | 5.27 | Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor. ( Aramideh, M; Bienfait, H; Booij, J; Boon, AJW; Brans, JWM; Delnooz, CCS; Dijk, JM; Dreissen, YEM; Hoogerwaard, E; Hovestadt, A; Kamphuis, DJ; Koelman, JHTM; Munts, AG; Skorvanek, M; Smit, M; Speelman, JD; Tijssen, MAJ; van der Salm, SMA; Zoons, E, 2018) |
| " Low dose citalopram reversed both scopolamine- and THC-induced impairment of spatial memory, suppressed ECS-induced immobilization reversed the THC-induced decrease of acetylcholine (ACh) release in the dorsal hippocampus in vivo microdialysis, and enhanced tremors induced by oxotremorine, a muscarinic M1 receptor agonist." | 3.73 | Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. ( Egashira, N; Fujioka, M; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Matsushita, M; Mishima, K; Nishimura, R; Shoyama, Y, 2006) |
| " According to a previous in vitro study, this pharmacokinetic interaction occurs on the level of CYP2C19, but also of CYP2D6 and CYP3A4 which, in contrast to CYP1A2, contribute to the N-demethylation of citalopram and which are stereoselectively inhibited by fluvoxamine." | 2.68 | Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. ( Baumann, P; Bertschy, G; Bondolfi, G; Chautems, C; Rochat, B, 1996) |
| "Side effects such as myoclonus and tremor are rare when treating with selective serotonin reuptake inhibitors (SSRIs)." | 1.42 | [Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis]. ( Bode, M; Forsberg-Gillving, M; Sindrup, SH, 2015) |
| "Tremor is the second most common neurological adverse effect in patients receiving treatment with SSRIs." | 1.32 | Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats. ( Al Deeb, S; Al Kadasah, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zoons, E | 1 |
| Booij, J | 1 |
| Delnooz, CCS | 1 |
| Dijk, JM | 1 |
| Dreissen, YEM | 1 |
| Koelman, JHTM | 1 |
| van der Salm, SMA | 1 |
| Skorvanek, M | 1 |
| Smit, M | 1 |
| Aramideh, M | 1 |
| Bienfait, H | 1 |
| Boon, AJW | 1 |
| Brans, JWM | 1 |
| Hoogerwaard, E | 1 |
| Hovestadt, A | 1 |
| Kamphuis, DJ | 1 |
| Munts, AG | 1 |
| Speelman, JD | 1 |
| Tijssen, MAJ | 1 |
| Forsberg-Gillving, M | 1 |
| Bode, M | 1 |
| Sindrup, SH | 1 |
| Go, AC | 1 |
| Golightly, LK | 1 |
| Barber, GR | 1 |
| Barron, MA | 1 |
| Sánchez, C | 1 |
| Kreilgaard, M | 1 |
| Arshaduddin, M | 1 |
| Al Kadasah, S | 1 |
| Biary, N | 1 |
| Al Deeb, S | 1 |
| Al Moutaery, K | 1 |
| Tariq, M | 1 |
| Tarlaci, S | 1 |
| Egashira, N | 1 |
| Matsumoto, Y | 1 |
| Mishima, K | 1 |
| Iwasaki, K | 1 |
| Fujioka, M | 1 |
| Matsushita, M | 1 |
| Shoyama, Y | 1 |
| Nishimura, R | 1 |
| Fujiwara, M | 1 |
| Bondolfi, G | 1 |
| Chautems, C | 1 |
| Rochat, B | 1 |
| Bertschy, G | 1 |
| Baumann, P | 1 |
| Takeuchi, H | 1 |
| Yatsugi, S | 1 |
| Hatanaka, K | 1 |
| Nakato, K | 1 |
| Hattori, H | 1 |
| Sonoda, R | 1 |
| Koshiya, K | 1 |
| Fujii, M | 1 |
| Yamaguchi, T | 1 |
2 trials available for citalopram and Tremor
| Article | Year |
|---|---|
Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor.
Topics: Adult; Aged; Aged, 80 and over; Citalopram; Cross-Over Studies; Double-Blind Method; Dystonic Disord | 2018 |
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Resistance; Drug Synergism; Drug | 1996 |
7 other studies available for citalopram and Tremor
| Article | Year |
|---|---|
[Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis].
Topics: Citalopram; Electroencephalography; Female; Humans; Liver Cirrhosis; Middle Aged; Myoclonus; Selecti | 2015 |
Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.
Topics: Acetamides; Anti-Infective Agents; Citalopram; Drug Interactions; Female; Humans; Linezolid; Male; M | 2010 |
R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Citalopram; Corticosterone; Dose-Response Relationsh | 2004 |
Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; | 2004 |
Citalopram-induced jaw tremor.
Topics: Citalopram; Female; Humans; Jaw; Masseter Muscle; Middle Aged; Selective Serotonin Reuptake Inhibito | 2004 |
Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.
Topics: Animals; Brain Chemistry; Citalopram; Dronabinol; Electroshock; Hallucinogens; Male; Memory Disorder | 2006 |
Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
Topics: Animals; Citalopram; Fluoxetine; Learning; Mice; Mice, Inbred ICR; Morpholines; Olfactory Bulb; Oxot | 1997 |